Evidence map›Paper›PMID 41231733›Full record

ArticleDermatology (Basel, Switzerland)2026

Incidence of Tattoo-Associated Melanoma in the Netherlands (1991-2023): A Nationwide Registry Study.

Joey J J P Karregat, Kim Schipper, Albert Wolkerstorfer, Elisabeth H Jaspars, Norbertus A Ipenburg, Nicolas Kluger, Yannick S Elshot

Erratum issuedAbstract read
In one paragraph

Article in Dermatology (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Joey J J P KarregatDepartment of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands, j.karregat@amsterdamumc.nl.
Kim SchipperDepartment of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Albert WolkerstorferDepartment of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Elisabeth H JasparsDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Norbertus A IpenburgDepartment of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Nicolas KlugerDepartment of Dermatology, Tampere University Hospital, Tampere, Finland.
Yannick S ElshotDepartment of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

<p>Introduction: Tattooing is an increasingly prevalent practice that is associated with various clinical complications. The carcinogenic potential of tattoo pigments remains unclear. While 45 case reports have described melanomas colocalizing with tattoos thus far, a pathogenetic link between tattoos and melanomas remains unproven. No nationwide epidemiological study has investigated the incidence of tattoo-associated melanoma (TAM). This study's objectives are to determine the incidence of TAM in the Netherlands from 1991 to 2023, analyse TAM characteristics and patient demographics, and compare these findings with melanoma data from the general Dutch population during the same period.

methodsData were obtained from the nationwide network and registry of histo- and cytopathology in the Netherlands (PALGA). Malignant and benign melanocytic lesions on the tattooed skin were included. Patient demographics and melanoma characteristics were extracted and analysed. Data from the Netherlands Cancer Registry (NKR) were used for comparison.

resultsFrom 1991 to 2023, 94 TAMs and 467 benign melanocytic lesions (BMLs) on tattoos were identified. The annual incidence of TAMs has increased over time. TAMs were diagnosed at an overall median age of 48.0 years, predominantly in males (64.9%). The median Breslow thickness was 0.9 mm, and most TAMs were TNM stage I (76.6%). The number needed to excise was 6.0.

conclusionNinety-four unique TAMs were identified in the Netherlands, which makes the largest case series to date. However, TAM incidence remained low (0.07%) compared to the total melanoma incidence, indicating that tattoos likely do not increase the risk of melanoma. A diagnostic delay from obscuring was considered unlikely based on the presented findings. This nationwide cohort study found no evidence supporting a causal relationship between tattoos and melanoma. </p>.

Indexed as

MelanomaSkin NeoplasmsTattooingAdolescentAdultAgedFemaleHumansIncidenceMaleMiddle AgedNetherlandsRegistriesYoung AdultDermato-oncologyMelanomaRetrospective cohortTattooTattoo pigment

Identifiers

PMID41231733
PMCPMC12716847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.